Factors Contributing to the Risk of Venous Thromboembolism
DOI:
https://doi.org/10.47611/jsrhs.v11i3.3165Keywords:
Venous Thromboembolism, Genetic Risk Factors, Non-genetic Risk Factors, Anticoagulant, Coagulation, ProteinAbstract
Both the deep vein thrombosis and pulmonary embolism are classified into venous thromboembolism (VTE). Risk factors for VTE are multifactorial with both genetic and non-genetic risk factors. Factor V Leiden, Prothrombin, and ABO blood group are three widely researched mutations highly associated to VTE while there are other rarer genetic risk factors such as Protein C, Protein S, Antithrombin deficiencies. Race and ethnicity, age, sex, diet and lifestyle are examples of some of the non-genetic risk factors for VTE; however, because non-genetic risk factors may be dependent of other environmental factors (such as the relationship between sex and oral contraceptives), their individual association to VTE needs further research.
Downloads
References or Bibliography
Raskob, G.E., et al., Thrombosis: a major contributor to global disease burden. Arterioscler Thromb Vasc Biol, 2014. 34(11): p. 2363-71.
Tripodi, A., D-dimer testing in laboratory practice. Clin Chem, 2011. 57(9): p. 1256-62.
Zhang, Z., et al., Trends in Hospitalization and In-Hospital Mortality From VTE, 2007 to 2016, in China. Chest, 2019. 155(2): p. 342-353.
Abe, K., et al., Venous thromboembolism as a cause of severe maternal morbidity and mortality in the United States. Semin Perinatol, 2019. 43(4): p. 200-204.
MacDougall, K. and A.C. Spyropoulos, Prevention of Venous Thromboembolism in Acutely Ill Medical Patients: A New Era. Semin Respir Crit Care Med, 2021. 42(2): p. 308-315.
Heit, J.A., et al., Familial segregation of venous thromboembolism. J Thromb Haemost, 2004. 2(5): p. 731-6.
Abildgaard, U., [Olav Egeberg--hereditary antithrombin deficiency and thrombophilia]. Tidsskr Nor Laegeforen, 2001. 121(5): p. 604-5.
Hotoleanu, C., Genetic Risk Factors in Venous Thromboembolism. Adv Exp Med Biol, 2017. 906: p. 253-272.
Kujovich, J.L., Factor V Leiden thrombophilia. Genet Med, 2011. 13(1): p. 1-16.
Folsom, A.R., et al., A prospective study of venous thromboembolism in relation to factor V Leiden and related factors. Blood, 2002. 99(8): p. 2720-5.
van Langevelde, K., et al., Broadening the factor V Leiden paradox: pulmonary embolism and deep-vein thrombosis as 2 sides of the spectrum. Blood, 2012. 120(5): p. 933-46.
Shaya, S.A., R.J. Westrick, and P.L. Gross, Thrombus stability explains the factor V Leiden paradox: a mouse model. Blood Adv, 2019. 3(21): p. 3375-3378.
Zöller, B., et al., Factor V Leiden paradox in a middle-aged Swedish population: A prospective study. Vasc Med, 2018. 23(1): p. 52-59.
Krishnaswamy, S., The transition of prothrombin to thrombin. J Thromb Haemost, 2013. 11 Suppl 1(0 1): p. 265-76.
Jadaon, M.M., Epidemiology of Prothrombin G20210A Mutation in the Mediterranean Region. Mediterr J Hematol Infect Dis, 2011. 3(1): p. e2011054.
Miyawaki, Y., et al., Thrombosis from a prothrombin mutation conveying antithrombin resistance. N Engl J Med, 2012. 366(25): p. 2390-6.
Takagi, Y., et al., Antithrombin-resistant prothrombin Yukuhashi mutation also causes thrombomodulin resistance in fibrinogen clotting but not in protein C activation. Thromb Res, 2014. 134(4): p. 914-7.
Silver, R.M., et al., Prothrombin gene G20210A mutation and obstetric complications. Obstet Gynecol, 2010. 115(1): p. 14-20.
Bank, I., et al., Prothrombin 20210A mutation: a mild risk factor for venous thromboembolism but not for arterial thrombotic disease and pregnancy-related complications in a family study. Arch Intern Med, 2004. 164(17): p. 1932-7.
Zhou, S. and I. Welsby, Is ABO blood group truly a risk factor for thrombosis and adverse outcomes? World J Cardiol, 2014. 6(9): p. 985-92.
Masias, C. and S.R. Cataland, The role of ADAMTS13 testing in the diagnosis and management of thrombotic microangiopathies and thrombosis. Blood, 2018. 132(9): p. 903-910.
Smith, N.L., et al., Novel associations of multiple genetic loci with plasma levels of factor VII, factor VIII, and von Willebrand factor: The CHARGE (Cohorts for Heart and Aging Research in Genome Epidemiology) Consortium. Circulation, 2010. 121(12): p. 1382-92.
Ohira, T., et al., ABO blood group, other risk factors and incidence of venous thromboembolism: the Longitudinal Investigation of Thromboembolism Etiology (LITE). J Thromb Haemost, 2007. 5(7): p. 1455-61.
Morange, P.E., et al., Biological and genetic factors influencing plasma factor VIII levels in a healthy family population: results from the Stanislas cohort. Br J Haematol, 2005. 128(1): p. 91-9.
Dentali, F., et al., Non-O blood type is the commonest genetic risk factor for VTE: results from a meta-analysis of the literature. Semin Thromb Hemost, 2012. 38(5): p. 535-48.
Wildhagen, K.C., et al., The structure-function relationship of activated protein C. Lessons from natural and engineered mutations. Thromb Haemost, 2011. 106(6): p. 1034-45.
Lu, Y., et al., Role of Gly197 in the structure and function of protein C. Biochim Biophys Acta Gen Subj, 2021. 1865(6): p. 129892.
Dahlbäck, B., Advances in understanding pathogenic mechanisms of thrombophilic disorders. Blood, 2008. 112(1): p. 19-27.
Mateo, J., et al., Laboratory evaluation and clinical characteristics of 2,132 consecutive unselected patients with venous thromboembolism--results of the Spanish Multicentric Study on Thrombophilia (EMET-Study). Thromb Haemost, 1997. 77(3): p. 444-51.
ten Kate, M.K. and J. van der Meer, Protein S deficiency: a clinical perspective. Haemophilia, 2008. 14(6): p. 1222-8.
Seligsohn, U. and A. Lubetsky, Genetic susceptibility to venous thrombosis. N Engl J Med, 2001. 344(16): p. 1222-31.
Patnaik, M.M. and S. Moll, Inherited antithrombin deficiency: a review. Haemophilia, 2008. 14(6): p. 1229-39.
Tait, R.C., et al., Prevalence of antithrombin deficiency in the healthy population. Br J Haematol, 1994. 87(1): p. 106-12.
Wells, P.S., et al., Prevalence of antithrombin deficiency in healthy blood donors: a cross-sectional study. Am J Hematol, 1994. 45(4): p. 321-4.
Hotoleanu, C., et al., The importance of homozygous polymorphisms of methylenetetrahydrofolate reductase gene in romanian patients with idiopathic venous thromboembolism. Balkan Med J, 2013. 30(2): p. 197-203.
Undas, A., J. Brozek, and A. Szczeklik, Homocysteine and thrombosis: from basic science to clinical evidence. Thromb Haemost, 2005. 94(5): p. 907-15.
Liu, F., et al., MTHFR A1298C and C677T Polymorphisms Are Associated with Increased Risk of Venous Thromboembolism: A Retrospective Chart Review Study. Acta Haematol, 2017. 138(4): p. 208-215.
Germain, M., et al., Meta-analysis of 65,734 individuals identifies TSPAN15 and SLC44A2 as two susceptibility loci for venous thromboembolism. American journal of human genetics, 2015. 96(4): p. 532-542.
Hinds, D.A., et al., Genome-wide association analysis of self-reported events in 6135 individuals and 252 827 controls identifies 8 loci associated with thrombosis. Human molecular genetics, 2016. 25(9): p. 1867-1874.
Lindström, S., et al., Genomic and transcriptomic association studies identify 16 novel susceptibility loci for venous thromboembolism. Blood, 2019. 134(19): p. 1645-1657.
Lindström, S., et al., Genomic and transcriptomic association studies identify 16 novel susceptibility loci for venous thromboembolism. Blood, 2019. 134(19): p. 1645-1657.
White, R.H., et al., Racial and gender differences in the incidence of recurrent venous thromboembolism. Thromb Haemost, 2006. 96(3): p. 267-73.
Zakai, N.A., et al., Racial and regional differences in venous thromboembolism in the United States in 3 cohorts. Circulation, 2014. 129(14): p. 1502-9.
Deitelzweig, S.B., et al., Venous thromboembolism in the US: does race matter? J Thromb Thrombolysis, 2011. 31(2): p. 133-8.
White, R.H. and C.R. Keenan, Effects of race and ethnicity on the incidence of venous thromboembolism. Thromb Res, 2009. 123 Suppl 4: p. S11-7.
Liew, N.C., et al., Asian venous thromboembolism guidelines: prevention of venous thromboembolism. Int Angiol, 2012. 31(6): p. 501-16.
Silverstein, M.D., et al., Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med, 1998. 158(6): p. 585-93.
Bell, E.J., et al., Lifetime Risk of Venous Thromboembolism in Two Cohort Studies. Am J Med, 2016. 129(3): p. 339.e19-26.
Luxembourg, B., et al., Intrinsic clotting factors in dependency of age, sex, body mass index, and oral contraceptives: definition and risk of elevated clotting factor levels. Blood Coagul Fibrinolysis, 2009. 20(7): p. 524-34.
Biguzzi, E., et al., Rise of levels of von Willebrand factor and factor VIII with age: Role of genetic and acquired risk factors. Thromb Res, 2021. 197: p. 172-178.
Fimognari, F.L., et al., Age, cancer and the risk of venous thromboembolism. Crit Rev Oncol Hematol, 2005. 55(3): p. 207-12.
Sallah, S., J.Y. Wan, and N.P. Nguyen, Venous thrombosis in patients with solid tumors: determination of frequency and characteristics. Thromb Haemost, 2002. 87(4): p. 575-9.
Baron, J.A., et al., Venous thromboembolism and cancer. Lancet, 1998. 351(9109): p. 1077-80.
Naess, I.A., et al., Incidence and mortality of venous thrombosis: a population-based study. J Thromb Haemost, 2007. 5(4): p. 692-9.
Christiansen, S.C., et al., Sex difference in risk of recurrent venous thrombosis and the risk profile for a second event. J Thromb Haemost, 2010. 8(10): p. 2159-68.
Bleker, S.M., M. Coppens, and S. Middeldorp, Sex, thrombosis and inherited thrombophilia. Blood Rev, 2014. 28(3): p. 123-33.
Kyrle, P.A., et al., The risk of recurrent venous thromboembolism in men and women. N Engl J Med, 2004. 350(25): p. 2558-63.
Roach, R.E., et al., Sex difference in risk of second but not of first venous thrombosis: paradox explained. Circulation, 2014. 129(1): p. 51-6.
Horvei, L.D., et al., Joint effects of prothrombotic genotypes and body height on the risk of venous thromboembolism: the Tromsø study. J Thromb Haemost, 2018. 16(1): p. 83-89.
Fowkes, F.J., J.F. Price, and F.G. Fowkes, Incidence of diagnosed deep vein thrombosis in the general population: systematic review. Eur J Vasc Endovasc Surg, 2003. 25(1): p. 1-5.
Severinsen, M.T., et al., Body height and sex-related differences in incidence of venous thromboembolism: a Danish follow-up study. Eur J Intern Med, 2010. 21(4): p. 268-72.
Lutsey, P.L., et al., Diet and incident venous thromboembolism: the Iowa Women's Health Study. Am Heart J, 2009. 157(6): p. 1081-7.
Steffen, L.M., et al., Greater fish, fruit, and vegetable intakes are related to lower incidence of venous thromboembolism: the Longitudinal Investigation of Thromboembolism Etiology. Circulation, 2007. 115(2): p. 188-95.
Varraso, R., et al., Prospective study of diet and venous thromboembolism in US women and men. Am J Epidemiol, 2012. 175(2): p. 114-26.
Yuan, S., et al., Lifestyle factors and venous thromboembolism in two cohort studies. Thromb Res, 2021. 202: p. 119-124.
Yuan, S., et al., Anti-inflammatory diet and venous thromboembolism: Two prospective cohort studies. Nutr Metab Cardiovasc Dis, 2021. 31(10): p. 2831-2838.
Gregson, J., et al., Cardiovascular Risk Factors Associated With Venous Thromboembolism. JAMA Cardiol, 2019. 4(2): p. 163-173.
Branchford, B.R. and S.L. Carpenter, The Role of Inflammation in Venous Thromboembolism. Front Pediatr, 2018. 6: p. 142.
van Stralen, K.J., et al., Regular sports activities decrease the risk of venous thrombosis. J Thromb Haemost, 2007. 5(11): p. 2186-92.
Borch, K.H., et al., Physical activity and risk of venous thromboembolism. The Tromso study. Haematologica, 2010. 95(12): p. 2088-94.
Shen, J.H., et al., Comparison of the Wells score with the revised Geneva score for assessing suspected pulmonary embolism: a systematic review and meta-analysis. J Thromb Thrombolysis, 2016. 41(3): p. 482-92.
Published
How to Cite
Issue
Section
Copyright (c) 2022 Yihang Chen; Mr. Ali Alamdar Shah Syed
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Copyright holder(s) granted JSR a perpetual, non-exclusive license to distriute & display this article.
